Osteoporosis Home > Osteoporosis Treatment
MedicationsThere are a number of medications currently approved for treating osteoporosis, including:
- Alendronate (Fosamax®)
- Risedronate (Actonel®)
- Risedronate delayed-release (Atelvia™)
- Ibandronate (Boniva®)
- Zoledronic acid (Reclast®)
- Calcitonin (Miacalcin®, Fortical®)
- Raloxifene (Evista®)
- Estrogen therapy (ET) or hormone therapy (HT)
- Parathyroid hormone or teriparatide (Forteo®)
- Denosumab (Prolia™).
This drug belongs to a class of drugs called bisphosphonates and is approved for both osteoporosis prevention and treatment. It is used to treat bone loss from the long-term use of osteoporosis-causing medications and is also used for osteoporosis in men. In postmenopausal women, it has shown to be effective at reducing bone loss, increasing bone density in the spine and hip, and reducing the risk of spine and hip fractures.
Like alendronate, risedronate is also a bisphosphonate. It is approved for:
- Osteoporosis prevention and treatment
- Bone loss from the long-term use of osteoporosis-causing medications
- Osteoporosis in men.
Risedronate has been shown to slow bone loss, increase bone density, and reduce the risk of spine and non-spine fractures.